Erlocip 150mg tablet - Erlotinib Uses & Side effects
Erlocip 150mg
Erlocip 150mg tablet is used as continuance therapy, in patients with long lasting or metastasis non small cell lung carcinoma, whose disease has not get advance after four cycles with platinum based first line therapy.
Erlocip is used in this condition only after the failure of one prior chemotherapy regimen. No clinical advantages occur while using Erlocip with platinum based compounds like carboplatin, gemcitabine or cisplatin.
Erlocip is used in this condition only after the failure of one prior chemotherapy regimen. No clinical advantages occur while using Erlocip with platinum based compounds like carboplatin, gemcitabine or cisplatin.
Product Details
Trade name :Erlocip
Active component : Erlotinib
Strength :150 mg
Manufactured by :Cipla Ltd.
Dosage Form :Tablets
Pack :Pack of 30 Tablets
Erlotinib mechanism of action
Erlocip has pharmacological effects like anti-neoplastic activity, which exhibits its action by inhibiting the intracellular phosphorylation of tyrosine kinase related with (EGFR) epidermal growth factor receptor. This EGFR signaling pathway is present on the surface of the tumor cells, this EGFR signaling is a critical pathway that involves in the treatment of effective cancer therapies. Thus results as inhibition causes interfere with signal transduction and lead to cell lyses. Cyclin dependent kinase are protein kinases, it should be characterised by the support of subunit as cyclin.
Erlocip 150mg |
Erlotinib Side Effects
Erlocip has effective and potency in elder patients who are failure to treat List of various erlotinib side ffects as sycg as, Some common various erlotinib side effects are Diarrhea, Fatigue, Anorexia, Pruritus, Acne, Dermatitis, Dry skin, Loss of weight, Paronychia, Cough, Vomiting, Conjunctivitis, Keratoconjuctivities sicca, Abdominal pain, Stomatits, Infection, nausea, Bone pain, Alopecia, Anxiety, Neuropathy, Renal disorders, hepatic disorders, ocular disorders, skin, hair and nail disorders.
During the therapy, some undesirable effects like; Paronychia, Bulbous, blistering and exploitative skin conditions like Stevens Johnson’s syndrome. Gastrointestinal perforation, Hepatic failure occurs during monotherapy or combination with other chemotherapy agents.
Prescription Medication Policy
Anti-Cancer-Drugs.com, a fully licensed and regulated pharmacy, takes all precautions to strictly abide by the laws and regulations set forth in the dispensing of prescription medications. By placing the order for your prescription medicines, you acknowledge and accept the following terms regarding the purchase of any prescription medicines.
Comments
Post a Comment